|
Volumn 67, Issue 4, 2010, Pages 254-
|
FDA approves tocilizumab to treat rheumatoid arthritis
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
TOCILIZUMAB;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
CLINICAL TRIAL;
DIGESTIVE SYSTEM PERFORATION;
DRUG APPROVAL;
DRUG DOSE INCREASE;
DRUG MARKETING;
DRUG PACKAGING;
HEADACHE;
HUMAN;
HYPERTENSION;
LIVER DISEASE;
NOTE;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
RHINITIS;
SIDE EFFECT;
SORE THROAT;
TREATMENT DURATION;
UPPER RESPIRATORY TRACT INFECTION;
|
EID: 77249105418
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/news100012 Document Type: Note |
Times cited : (15)
|
References (0)
|